Differential polyadenylation of the mutant vasopressin mRNA during development of Brattleboro rats

S Fehr1, H Schmale, D Richter

  • 1Institut für Zellbiochemie und klinische Neurobiologie, Universitäts-Krankenhaus, Eppendorf, Hamburg, FRG.

Insights

Vasopressin mRNA expression begins earlier in normal rats than in Brattleboro rats. Mutant vasopressin transcripts show developmental changes in polyadenylation, impacting gene expression.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Developmental Biology

Background:

  • Vasopressin is a crucial neurohormone involved in regulating water balance and blood pressure.
  • The Brattleboro rat is a genetic model with a defective vasopressin gene, exhibiting diabetes insipidus.

Purpose of the Study:

  • To investigate the developmental expression patterns of vasopressin mRNA in normal and Brattleboro rats.
  • To analyze differences in vasopressin mRNA size and polyadenylation during development between the two rat strains.

Main Methods:

  • In situ hybridization of hypothalamic sections to detect mRNA.
  • Analysis of mRNA size and polyadenylation using RNase H and oligo(dT) treatment.

Main Results:

  • Vasopressin mRNA appears at embryonic day 15 in Wistar rats and not before fetal day 18 in Brattleboro rats.
  • Oxytocin gene expression begins at fetal day 19 in both strains.
  • Adult Brattleboro rats exhibit larger vasopressin transcripts due to extended poly(A) sequences, unlike normal rats.

Conclusions:

  • The mutant vasopressin gene transcript in Brattleboro rats undergoes cellular-specific differential polyadenylation during development.
  • This altered polyadenylation may contribute to the physiological differences observed in Brattleboro rats.